Immunology patient resources

Our commitment to elevating patient care in immunology

At Bristol Myers Squibb, we are working to deliver meaningful solutions that address unmet needs in rheumatology, gastroenterology, dermatology and pulmonology. While there has been progress with medicines for immune-mediated diseases, people living with these conditions may not respond to available treatments. Many continue to endure chronic symptoms and disease progression that can take a toll on their daily life.

 

Our goal is to restore some of what immune-mediated diseases have taken away — empowering patients and their loved ones to take back their lives.

Immunology focus areas

Rheumatology

Rheumatic diseases can be debilitating for the tens of millions worldwide who often live with chronic pain that can make simple tasks and everyday activities challenging. 

Building on more than 20 years of experience, at Bristol Myers Squibb we are following the science to tailor therapies to a person’s individual needs, improve outcomes and expand treatment options for rheumatic diseases such as rheumatoid arthritis (RA), psoriatic arthritis, lupus and ankylosing spondylitis. Through our ongoing research, educational resources and partnerships with the community, our goal is to provide new solutions that advance care and provide the potential for remission.

Our commitment to elevating patient care in immunology

Rheumatoid arthritis

Learn more about RA, its symptoms and its potential impact on patients. 

Psoriatic arthritis

Learn more about psoriatic arthritis, a chronic, immune-mediated disease that impacts the joints and skin. 

Juvenile idiopathic arthritis

Learn more about juvenile idiopathic arthritis and how the disease may impact patients.

Lupus

Learn more about lupus, its symptoms and its potential impact on patients.

Systemic lupus erythematosus

Learn more about systemic lupus erythematosus, a chronic immune-mediated disease that can affect almost any organ.

Ankylosing spondylitis

Learn more about ankylosing spondylitis, its symptoms and its potential impact on patients. 

Sjögrens Disease

Learn more about Sjögrens Disease, its symptoms and its potential impact on patients. 

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.

Gastroenterology

Bristol Myers Squibb is pursuing innovative research to potentially change the course of gastrointestinal immune-mediated diseases, including inflammatory bowel disease (IBD) (which includes ulcerative colitis and Crohn's disease) and eosinophilic esophagitis (EoE), a chronic, progressive condition that affects the esophagus. 

Our innovations have the potential to provide relief and remission to people living with these conditions. Through our research, educational resources and connections with the community to provide support, our goal is to help empower patients to take back what these diseases often take away.

Winter's story: living with ulcerative colitis

Learn about Winter's journey of living with ulcerative colitis for more than 20 years.

One woman's account of living with ulcerative colitis

Laurie shares the inspiring story of how she persevered as a working mother and patient living with ulcerative colitis.

Leading the charge against eosinophilic esophagitis

Discover how Bristol Myers Squibb is leading the way in improving Eosinophilic Esophagitis treatment and early diagnosis for improved patient well being.

Crohn's disease

Learn more about Crohn’s disease, a gastrointestinal immune-mediated disease that affects patients worldwide.

Ulcerative colitis

Learn more about ulcerative colitis, its symptoms and effects on patients. 

Eosinophilic esophagitis 

Learn more about EoE, a chronic, progressive, immune-mediated disease that affects the esophagus.

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.

Dermatology

At Bristol Myers Squibb, we are advancing innovative solutions to address the pressing needs that continue to exist for people living with dermatologic immune-mediated diseases. Our pioneering research is leading to the potential for safe and effective new medicines.

We are committed to providing resources that help with disease management and support, pursuing new treatments for diseases like psoriasis and atopic dermatitis and exploring a broad range of serious dermatologic conditions in our early research.  

Patient experience of living with psoriasis

Learn about Royce Thomas' experience of living with psoriasis, as he speaks with Frida Dunger Johnsson, executive director of IFPA, and the importance of supporting the global community of individuals impacted by psoriatic disease.

Understanding key psoriasis outcome measures 

Bristol Myers Squibb is committed to educating patients and healthcare providers about psoriasis so that they can work together to determine a disease management plan.

 

Psoriasis around the world 

Hear from patients, advocates and healthcare providers from around the world on the burden of psoriasis and learn about the health disparities faced by patients of color.

Psoriasis

Learn more about psoriasis, a widely prevalent, chronic, systemic immune-mediated disease.

Psoriatic arthritis

Learn more about psoriatic arthritis, a chronic, immune-mediated disease that impacts the joints and skin.

Atopic dermatitis

Learn more about atopic dermatitis, its symptoms and effects on patients. 

Psoriasis treatment types

Learning more about different types of treatment options can help people work with their healthcare providers on the approach best suited to their needs.

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.

Pulmonology

Bristol Myers Squibb is committed to applying expertise regarding the role of fibrosis in the development of several immune-mediated diseases to advance new treatments that go beyond symptom relief and address the underlying causes of disease.

Living with Idiopathic Pulmonary Fibrosis

Read the inspiring story of Mal Doyle, a patient living with Idiopathic Pulmonary Fibrosis, and learn how Bristol Myers Squibb is working towards developing potential treatments to slow the progression of pulmonary fibrosis.

Lysophosphatidic acid receptor 1 (LPA1) in pulmonary fibrosis

Learn more about Bristol Myers Squibb's commitment to developing new treatments for immune-mediated diseases with our research on the LPA1 receptor and its role in idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.